Concepedia

Adel Alblihy

AA

12

Publications

317

Citations

12

H-Index

2019

Active since

Affiliations

Nottingham University Hospitals NHS Trust(Current)

University of Nottingham

King Fahd Security College

Weill Cornell Medicine

Cornell University

Adel Alblihy is an author at Nottingham University Hospitals NHS Trust specializing in tumor biology, ovarian cancer, and cell biology.

Top concepts

Publications per year

2019–2023

12

Publications

12

ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers

Katia A. Mesquita, Muslim Alabdullah, Michaela Griffin et al. · Gynecologic Oncology · 2019 · 44 citations

, , +11

PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers

Reem Ali, Muslim Alabdullah, Adel Alblihy et al. · Cancer Letters · 2019 · 35 citations · Full text

, , +7

Mutational Landscape of Pirin and Elucidation of the Impact of Most Detrimental Missense Variants That Accelerate the Breast Cancer Pathways: A Computational Modelling Study

Muhammad Suleman, Muhammad Tahir ul Qamar, Shoaib Saleem et al. · Frontiers in Molecular Biosciences · 2021 · 34 citations · Full text

Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers

Reem Ali, Muslim Alabdullah, Mashael Algethami et al. · Theranostics · 2021 · 33 citations · Full text

Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers

Reem Ali, Adel Alblihy, Islam M. Miligy et al. · Oncogene · 2021 · 32 citations · Full text

Rows per page

1–5 of 12